Novel fondaparinux protocol for anticoagulation therapy in adults with renal failure and suspected heparin-induced thrombocytopenia: a retrospective review of institutional protocol
The literature recommends against the use of fondaparinux in patients with kidney failure and dialysis as it may, with repeated dosing, accumulate and put patients at risk of bleeding. The management of patien...
Source: BMC Clinical Pharmacology - Category: Drugs & Pharmacology Authors: Dania Ghaziri, Hassan Dehaini, Mayyas Msheik, Marwan Bahmad, Maya Zorkot and George Abi Saad Tags: Research Source Type: research
More News: Bleeding | Dialysis | Drugs & Pharmacology | Renal Failure | Thrombocytopenia | Urology & Nephrology